Stockscreener 앱 받기
3.19
2.74%
-0.09
전일 마감가:
$3.28
열려 있는:
$3.22
하루 거래량:
78,689
Relative Volume:
0.55
시가총액:
$120.50M
수익:
-
순이익/손실:
$-27.66M
주가수익비율:
-3.3579
EPS:
-0.95
순현금흐름:
$-24.36M
1주 성능:
-9.63%
1개월 성능:
-7.00%
6개월 성능:
-43.04%
1년 성능:
+60.30%
1일 변동 폭
$3.19
$3.35
1주일 범위
$3.14
$3.61
52주 변동 폭
$1.93
$5.885
Genelux Corp Stock (GNLX) Company Profile
명칭
Genelux Corp
전화
805-267-9889
주소
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
GNLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GNLX
Genelux Corp
|
3.19 | 123.86M | 0 | -27.66M | -24.36M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Genelux Corp Stock (GNLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-29 | 개시 | Guggenheim | Buy |
| 2024-08-28 | 개시 | ROTH MKM | Buy |
| 2023-11-27 | 개시 | H.C. Wainwright | Buy |
| 2023-09-12 | 개시 | Maxim Group | Buy |
| 2023-02-15 | 개시 | The Benchmark Company | Speculative Buy |
Genelux Corp 주식(GNLX)의 최신 뉴스
Is a relief rally coming for Genelux Corporation holdersRisk Management & Free Technical Confirmation Trade Alerts - Newser
Technical analysis overview for Genelux Corporation stock [2025 Geopolitical Influence]Free Safe Entry Trade Signal Reports - Newser
How sentiment analysis helps forecast Genelux CorporationReal-Time Investment Signal Forecast with AI - Newser
Genelux Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Genelux Corp.’s Innovative Cancer Treatment Approach Earns Buy Rating - TipRanks
What to do if you’re stuck in Genelux CorporationFree Community Entry Consensus Trade Ideas - Newser
Advanced analytics toolkit walkthrough for Genelux CorporationWeekly Gain Forecast with Momentum Indicators - Newser
News impact scoring models applied to Genelux CorporationStock Entry Point Planner with Volume Spike - Newser
How to escape a deep drawdown in Genelux CorporationIntraday Signal Forecast for Fast Traders - Newser
Why Genelux Corporation stock attracts strong analyst attentionFree AI Driven Buy Alert Trade Blueprint - Newser
Promising Outlook for Genelux Corp. with Olvi-Vec Advancements and Strong Financial Position - TipRanks
Genelux Corporation stock prediction for this weekFree Investment Playbook for Growing Markets - Newser
Genelux Corp.'s Olvi-Vec: A Promising Oncology Treatment with a Buy Rating - AInvest
Genelux Corporation stock daily chart insightsMulti-Bagger Detection with Trend Tools - Newser
Genelux Corp expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Promising Potential of Genelux Corp.’s Olvi-Vec in Oncology: A Buy Rating Based on Clinical Data and Strategic Developments - TipRanks
Can trapped investors hope for a rebound in Genelux CorporationWealth Accumulation Outlook for Safe Investors - Newser
Genelux reports Q2 EPS (20c), consensus (22c) - TipRanks
Genelux Q2 Earnings Exceed Expectations with $0.20 GAAP EPS and $28.1M in Cash and Investments - AInvest
Genelux Q2 Earnings: Phase 3 Ovarian Cancer Trial On Track, 71% Success in Lung Cancer | GNLX Stock News - Stock Titan
Developing predictive dashboards with Genelux Corporation dataFree Daily Top Performing Stock Insights - Newser
Does Genelux Corporation show high probability of reboundAI Intraday Market Movement Prediction Tool - Newser
Building trade automation scripts for Genelux CorporationPattern Recognition Based Market Move Prediction - Newser
Genelux Corporation Stock Approaches Key Moving AverageSwing Trade Entry With Volume Triggers Released - beatles.ru
What are the latest earnings results for Genelux CorporationMarket Forecast Signals For Fast Growth - Jammu Links News
How Genelux Corporation stock performs during market volatilityCapital Growth Summary Over Five Years - Newser
How to use a screener to detect Genelux Corporation breakoutsDividend Strategy Summary With 10-Year Outlook - Newser
Genelux Corporation Added to High Probability Setup ListHigh Conviction Intraday Stock Signals Detected - metal.it
How Efficient Is Genelux Corporation at Controlling Operating CostsRisk Aware Swing Trade Analysis Insights - Newser
Does Genelux Corporation stock perform well during market downturnsAchieve unparalleled market performance - Jammu Links News
Using AI based signals to follow Genelux CorporationEarnings Report Summary with Market Impact - Newser
Is it the right time to buy Genelux Corporation stockGet alerts on the hottest market movers - Jammu Links News
What drives Genelux Corporation stock priceBreakthrough investment results - Autocar Professional
Genelux Corporation Stock Analysis and ForecastTriple returns potential - Autocar Professional
Genelux stock maintains Buy rating at H.C. Wainwright amid sector news - Investing.com India
Genelux stock maintains Buy rating at H.C. Wainwright amid sector news By Investing.com - Investing.com South Africa
Promising Prospects for Genelux Corp.’s Olvi-Vec: A Buy Rating Based on Strong Clinical Trial Design and Efficacy - TipRanks
What analysts say about Genelux Corporation stockOutstanding risk-reward balance - jammulinksnews.com
Lucid Capital Initiates Coverage on Genelux with a Buy Rating, Setting a Price Target of $10. - AInvest
Lucid Capital Initiates Coverage of Genelux with Buy Rating and $10 Price Target - AInvest
Genelux Corp (GNLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.91%
3.06%
자본화:
|
볼륨(24시간):